arXiv Science⌕ Search

arXiv · 2611.18846

Multi-Assay Antibody Developability Prediction with Shared Structure-Language Representations

Abstract

Early assessment of antibody developability is critical in drug discovery, but computational approaches remain limited by the scarcity of experimental data. We explore two strategies for working within that limit. First, we designed per-residue physicochemical descriptors encoding the local structural environment, including new terms such as directional charge asymmetry and screened electrostatic potential. These feed a convolutional network, combined with protein language model (PLM) embeddings in a two-stream architecture: the two are encoded and predicted independently and merged only at the prediction stage. Second, a shared trunk with per-assay heads passes information between related assays. Both are implemented in the Multi-Assay Developability Model (MADM) and evaluated on eight assays: HIC, heparin affinity (HAC), AC-SINS, and polyspecificity ELISA against BVP, dsDNA, insulin, ovalbumin and soluble membrane proteins (SMP), with labels from 29 open sources. Structural descriptors match or exceed PLM embeddings (AbLang2, ESM2) on several assays; combining the streams gives a small but consistent gain in accuracy and reduces seed-to-seed variance. Multi-assay training raises Spearman rho for ovalbumin and SMP by about 0.1, where assays correlate and share sequence space. Under cluster-split cross-validation the strongest results are for HAC, ovalbumin, insulin, SMP and HIC (rho = 0.70-0.82); AC-SINS, BVP and dsDNA are weaker (0.50-0.55). In these three, sequence clusters largely coincide with data source, so a held-out fold measures transfer to differently calibrated measurements as well as to new sequences. On the 80-antibody GDPa3 hold-out, performance falls by rho around 0.1 for all but SMP (0.22). Transfer to the VHH panel of Ginkgo GDPa5 gives comparable results, and scFv validation against binary SMP labels yields F1 = 0.89, AUC = 0.95.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Daria B. Kokh. 2026-11-13. Multi-Assay Antibody Developability Prediction with Shared Structure-Language Representations. https://arxiv.science/abs/2611.18846

Citations retain the original authors and DOI and include this site’s record URL. If this discovery service contributed to your research, you can also cite arXiv Science by Indiciae: BibTeX · RIS.

KEEP EXPLORING

Related papers

Discovery of new antiviral agents through artificial intelligence: in vitro and in vivo results

In this research, we employed a deep reinforcement learning (RL)-based molecule design platform to generate a diverse set of compounds targeting the neuraminidase (NA) of influenza A and B viruses. A total of 60291 compounds were generated, of which 86.5% displayed superior physicochemical properties compared to oseltamivir. After narrowing down the selection through computational filters, nine compounds with non-sialic acid-like structures were selected for in vitro experiments. We identified two compounds, DS-22-inf-009 and DS-22-inf-021 that effectively inhibited the NAs of both influenza A and B viruses (IAV and IBV), including H275Y mutant strains at low micromolar concentrations. Molecular dynamics simulations revealed a similar pattern of interaction with amino acid residues as oseltamivir. In cell-based assays, DS-22-inf-009 and DS-22-inf-021 inhibited IAV and IBV in a dose-dependent manner with EC50 values ranging from 0.29 uM to 2.31 uM. Furthermore, animal experiments showed that both DS-22-inf-009 and DS-22-inf-021 exerted antiviral activity in mice, conferring 65% and 85% protection from IAV (H1N1 pdm09), and 65% and 100% protection from IBV (Yamagata lineage), respectively. Thus, these findings demonstrate the potential of RL to generate compounds with promising antiviral properties.

q-bio.BM↗

Agent-guided epitope excision enables economical de novo binder design

De novo protein design campaigns remain bottlenecked by the inference compute time required to generate and rank candidates, limiting wider functional exploration. Here, we introduce and evaluate an epitope excision approach that truncates targets to local interface windows to accelerate both backbone diffusion and structure prediction. Across 15 targets and 3,666 designs, excised windows closely reproduced full-target binding interfaces (median CαRMSD of 0.37 Å) and made it practical to design binders against the 719-residue extracellular domain of fibroblast activation protein alpha (FAP) by cutting RFdiffusion and AlphaFold3 GPU time by ~ 88% in one of the epitopes. Pairing this workflow with an agentic optimization loop allowed the system to autonomously identify catalytic-site targeting strategies. Under a fixed compute budget, a human-in-the-loop (HITL) workflow raised the computational hit rate from 5.06% to 9.33% while further cutting GPU hours by ~ 42%. We also found that omitting target multiple sequence alignments during refolding roughly substantially increased the apparent yield. Wet-lab validation with yeast display identified nanomolar binders from the generated designs with the HITL and the fully autonomous agent (human-out-of-the-loop, HOOTL) arms recovering more enriched designs than the PI-alone baseline. Together, target excision and agent-guided search offer a practical way to scale de novo binder design to large, therapeutically relevant proteins.

q-bio.BM↗

Cross-species digital xenocortication model delineates molecular correlates of human brain connectome

Cross-species digital xenocortication (CSDX) model based on pairing of a human brain structure with one or more mouse brain structures was constructed and implemented to dissect the molecular correlates of the human brain connectome. Design of the CSDX model is based on the assumption that a human brain region and its named mouse counterpart occupy corresponding positions in an evolutionary conserved mammalian brain connectome plan, so that a projection strength measured between two mouse structures is informative about the relation between the two human structures paired with them. In the CSDX model, gene expression for the node was measured in the human brain, while connection strength between two nodes was measured in the mouse brain. CSDX models of different parcellations were employed to explore the potential regulatory associations of brain connectome patterns and constituents of protein-protein interaction (PPI) cascades of hybrid assembly pathways of endogenous multiprotein complexes. Metrics of continuous engagement of the PPI cascade nucleated protein dimers of CORUM multiprotein complexes have been identified as statistical components of the multivariate transcriptome-connectome associations. It accounts for additional connectome associated variations beyond the five measured axes in the 82 nodes CSDX model. Comparisons of the seven arm models of transcriptome-connectome associations demonstrate that the mouse derived model generally fits the mouse brain connectome better, while the human derived model assigns a significantly larger fraction of its transcriptome-connectome association to unique rather than net shared contributions. This study nominates elite panels of top scoring candidate protein dimers and CORUM multiprotein complexes for follow up mechanistic studies of their potential roles in structural functional features governing mammalian brain connectome.

q-bio.BM↗